Literature DB >> 12117646

Volatile organic compounds as breath biomarkers for active and passive smoking.

Sydney M Gordon1, Lance A Wallace, Marielle C Brinkman, Patrick J Callahan, Donald V Kenny.   

Abstract

We used real-time breath measurement technology to investigate the suitability of some volatile organic compounds (VOCs) as breath biomarkers for active and passive smoking and to measure actual exposures and resulting breath concentrations for persons exposed to tobacco smoke. Experiments were conducted with five smoker/nonsmoker pairs. The target VOCs included benzene, 1,3-butadiene, and the cigarette smoke biomarker 2,5-dimethylfuran. This study includes what we believe to be the first measurements of 1,3-butadiene in smokers' and nonsmokers' breath. The 1,3-butadiene and 2,5-dimethylfuran peak levels in the smokers' breath were similar (360 and 376 microg/m(3), respectively); the average benzene peak level was 522 microg/m(3). We found higher peak values of the target chemicals and shorter residence times in the body than previously reported, probably because of the improved time resolution made possible by the continuous breath measurement method. The real-time breath analyzer also showed the presence of the chemicals after exposure in the breath of the nonsmokers, but at greatly reduced levels. Single breath samples collected in evacuated canisters and analyzed independently with gas chromatography/mass spectrometry confirmed the presence of the target compounds in the postexposure breath of the nonsmokers but indicated that there was some contamination of the breath analyzer measurements. This was likely caused by desorption of organics from condensed tar in the analyzer tubing and on the quartz fiber filter used to remove particles. We used the decay data from the smokers to estimate residence times for the target chemicals. A two-compartment exponential model generally gave a better fit to the experimental decay data from the smokers than a single-compartment model. Residence times for benzene, 1,3-butadiene, and 2,5-dimethylfuran ranged from 0.5 (1,3-butadiene) to 0.9 min (benzene) for tau1 and were essentially constant (14 min) for tau2. These findings will be useful in models of environmental tobacco smoke exposure and risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117646      PMCID: PMC1240915          DOI: 10.1289/ehp.02110689

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  31 in total

1.  Toxic volatile organic compounds in simulated environmental tobacco smoke: emission factors for exposure assessment.

Authors:  J M Daisey; K R Mahanama; A T Hodgson
Journal:  J Expo Anal Environ Epidemiol       Date:  1998 Jul-Sep

2.  Pharmacokinetics of benzene and toluene.

Authors:  A Sato; T Nakajima; Y Fujiwara; K Hirosawa
Journal:  Int Arch Arbeitsmed       Date:  1974

3.  Effect of smoking during pregnancy on the risk of cancer in children.

Authors:  C I Neutel; C Buck
Journal:  J Natl Cancer Inst       Date:  1971-07       Impact factor: 13.506

4.  Breath concentration as an index of the health risk from benzene. Studies on the accumulation and clearance of inhaled benzene.

Authors:  M Berlin; J C Gage; B Gullberg; S Holm; P Knutsson; C Eng; A Tunek
Journal:  Scand J Work Environ Health       Date:  1980-06       Impact factor: 5.024

5.  Species differences in the distribution of inhaled butadiene in tissues.

Authors:  J A Bond; A R Dahl; R F Henderson; L S Birnbaum
Journal:  Am Ind Hyg Assoc J       Date:  1987-10

6.  Benzene levels in ambient air and breath of smokers and nonsmokers in urban and pristine environments.

Authors:  R C Wester; H I Maibach; L D Gruenke; J C Craig
Journal:  J Toxicol Environ Health       Date:  1986

7.  Cancer risk in adulthood from early life exposure to parents' smoking.

Authors:  D P Sandler; R B Everson; A J Wilcox; J P Browder
Journal:  Am J Public Health       Date:  1985-05       Impact factor: 9.308

8.  The TEAM (Total Exposure Assessment Methodology) Study: personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota.

Authors:  L A Wallace; E D Pellizzari; T D Hartwell; C Sparacino; R Whitmore; L Sheldon; H Zelon; R Perritt
Journal:  Environ Res       Date:  1987-08       Impact factor: 6.498

9.  Exposure to toxic air contaminants in environmental tobacco smoke: an assessment for California based on personal monitoring data.

Authors:  S L Miller; S Branoff; W W Nazaroff
Journal:  J Expo Anal Environ Epidemiol       Date:  1998 Jul-Sep

10.  Maternal smoking during pregnancy and risk of childhood cancer.

Authors:  M Stjernfeldt; K Berglund; J Lindsten; J Ludvigsson
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

View more
  17 in total

1.  Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.

Authors:  Nadia I Georgieva; Gunnar Boysen; Narisa Bordeerat; Vernon E Walker; James A Swenberg
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

2.  Formation of 1,2:3,4-diepoxybutane-specific hemoglobin adducts in 1,3-butadiene exposed workers.

Authors:  Gunnar Boysen; Nadia I Georgieva; Narisa K Bordeerat; Radim J Sram; Pamela Vacek; Richard J Albertini; James A Swenberg
Journal:  Toxicol Sci       Date:  2011-10-14       Impact factor: 4.849

Review 3.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

Review 4.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

5.  Blood volatile organic compounds as potential biomarkers for amyotrophic lateral sclerosis: an animal study in the SOD1 G93A mouse.

Authors:  Hongquan Jiang; Changsong Wang; Ming Ren; Xiang Yin; Chunjie Chi; Lei Guo; Chaofu Ke; Honglin Feng; Enyou Li
Journal:  J Mol Neurosci       Date:  2014-04-09       Impact factor: 3.444

6.  Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer.

Authors:  Jiunn-Liang Tan; Zheng-Xin Yong; Chong-Kin Liam
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  Residual tobacco smoke: measurement of its washout time in the lung and of its contribution to environmental tobacco smoke.

Authors:  Giovanni Invernizzi; Ario Ruprecht; Cinzia De Marco; Paolo Paredi; Roberto Boffi
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

Review 8.  Reactive metabolites in the biotransformation of molecules containing a furan ring.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2012-10-24       Impact factor: 3.739

9.  Blood volatile compounds as biomarkers for colorectal cancer.

Authors:  Changsong Wang; Peng Li; Ailing Lian; Bo Sun; Xiaoyang Wang; Lei Guo; Chunjie Chi; Shanshan Liu; Wei Zhao; Suqi Luo; Zhigang Guo; Yang Zhang; Chaofu Ke; Guozhu Ye; Guowang Xu; Fengmin Zhang; Enyou Li
Journal:  Cancer Biol Ther       Date:  2013-11-01       Impact factor: 4.742

Review 10.  Exhaled breath analysis for lung cancer.

Authors:  Annette G Dent; Tom G Sutedja; Paul V Zimmerman
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.